-- 多伦多证券交易所午盘下跌180点,科技和材料板块领跌,两板块均下跌4.0%。 周一公布第一季度盈利超出预期的Celestica (CLS.TO)股价午盘下跌15%,至488.00加元。 能源和电信板块表现最佳,分别上涨2.6%和1.1%。Telus (T.TO)今日早些时候宣布与Technotree建立合作关系,股价上涨2.3%,成交量超过400万股。《环球邮报》报道称,TD Cowen将Telus的评级从“持有”上调至“买入”。 据加拿大广播公司(CBC)新闻报道,联邦政府将于今日下午4点公布春季经济报告,总理马克·卡尼暗示经济前景乐观,赤字低于预期。预算观察人士预计赤字将有所下降。 公司新闻方面,巴里克矿业(ABX.TO)周二发布最新消息,计划通过首次公开募股(IPO)出售其北美黄金资产持有的新公司的少数股权。对此,加拿大国家银行表示,其维持对巴里克矿业的“跑赢大盘”评级,理由是该公司估值折让、Fourmile项目未来进展顺利以及北美资产即将实现的价值。“Fourmile项目的勘探进展是公司重要的价值驱动因素,鉴于此前宣布的马里Loulo-Gounkoto项目已获解决,这进一步支持了我们重新评估其评级。随着公司重新聚焦于美洲(以内华达州为中心)黄金产量的增长以及运营的持续改进,我们认为未来其估值倍数有望实现更可持续的增长。”该银行补充道。
Related Articles
US Treasury Closing Levels
3:00 Tuesday vs 3:00 Monday2yr 99-26 vs 100-04; 3.842% vs 3.799%5yr 99-16+ vs 99-21+; 3.981% vs 3.947%10yr 98-06+ vs 98-10+; 4.351% vs 4.335%30yr 97-00 vs 96-31+; 4.941% vs 4.941%2/10 50.633 bps vs 53.307 bps5/30 95.813 bps vs 99.249 bps
Brown & Brown's Q1 Report Shows Organic Revenue Growth Under Continued Pressure, UBS Says
Brown & Brown's (BRO) Q1 report shows that the company's organic revenue growth continues to remain under pressure despite better than expected quarterly earnings per share and adjusted margins, UBS said in a note.The company's flat Q1 organic revenue growth was below UBS expectations of a 2% growth and consensus of 1.3%, UBS said on Monday. The metric further excluded $10 million in litigation related lost revenue, which was in-line with expectations, according to UBS.Looking ahead, Brown & Brown expects catastrophe property rates to continue to experience downward pressure in Q2, while economic growth should remain relatively stable, UBS said. The company's capital allocation will have a bias toward buybacks and paying down debt, while remaining active for specialty and smaller deals, UBS added.UBS maintained its neutral rating on the company's stock with an $81 price target.Shares of Brown & Brown were down over 6% in Tuesday trading.Price: $62.07, Change: $-4.06, Percent Change: -6.13%
TD Cowen Raises Incyte Price Target to $124 From $123
Incyte (INCY) has an average rating of overweight and mean price target of $109.10, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $94.83, Change: $-0.89, Percent Change: -0.93%